Healthcare technology company Intuitive Surgical Inc. (NASDAQ: ISRG) Wednesday reported a sharp increase in revenue and adjusted earnings for the first quarter
Earnings: Intuitive Surgical (ISRG) reports higher revenue and profit for Q1 2025
Categories
Health Care
Earnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced financial results for the first quarter of 2025, reporting a modest increase in
Infographic: How UnitedHealth Group (UNH) performed in Q1 2025
UnitedHealth Group (NYSE: UNH) reported its first quarter 2025 earnings results today. Total revenues were $109.6 billion compared to $99.8 billion in
Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported its first quarter 2025 earnings results today. Total sales increased 4% year-over-year to $10.35 billion. Organic sales
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today. Reported sales increased 2.4% year-over-year to $21.9 billion. Operational
UNH Earnings Preview: Will UnitedHealth’s Q1 earnings beat expectations?
Like many insurance companies, UnitedHealth Group (NYSE: UNH) generally demonstrates the ability to remain relatively resilient during economic downturns, mainly due to
Deals and R&D in focus as Johnson & Johnson gears up for Q1 earnings
For Johnson & Johnson (NYSE: JNJ), investments in its pipeline and exiting lower priority businesses remain central to its strategy in the
Walgreens Boots Alliance (WBA) Q2 2025 Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance (NASDAQ: WBA) reported its second quarter 2025 earnings results today. Sales increased 4.1% year-over-year to $38.6 billion. Sales growth
AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues decreased by
Walgreens Boots Alliance set to report Q2 earnings. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in health and wellness services, is preparing to report second-quarter results, with market
OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness
OS Therapies (NYSE: OSTX) is a cancer immunotherapy company engaged in the development of new treatments for osteosarcoma and other solid tumors.
Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance
Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided cautious first-quarter
Illumina (ILMN) expects adjusted EPS of approximately $4.50 for FY25
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) has issued fresh earnings guidance for fiscal 2025, to reflect tariff-related challenges to export. The company
Earnings Summary: Highlights of CooperCompanies (COO) Q1 2025 results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the first quarter of 2025, reporting an increase in revenues and
Earnings Summary: Highlights of Baxter International’s Q4 2024 report
Baxter International Inc. (NYSE: BAX) on Thursday announced financial results for the fourth quarter of 2024. The medical device maker's sales increased
MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported an increase in revenues and adjusted profit for the third quarter of
Earnings Summary: Moderna slips to loss in Q4; revenue down 66%
Biotechnology company Moderna, Inc. (NASDAQ: MRNA) has reported a net loss for the fourth quarter of 2024, compared to a profit last
Earnings: CVS Health reports a sharp fall in Q4 profit; revenue up 4%
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) reported mixed results for the fourth quarter of 2024, with revenues growing modestly and earnings
Key metrics from Biogen’s (BIIB) Q4 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today. Total revenue increased 3% year-over-year to $2.5 billion. Net
Earnings Summary: Humana’s Q4 2024 loss widens; revenue up 10%
Humana Inc. (NYSE: HUM), a leading health and well-being company, on Tuesday reported a wider net loss for the fourth quarter of
Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report
Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue. Net